DENVER, March 3, 2025 /PRNewswire/ -- Affineon Health, a leader in AI inbox automation for healthcare providers, today announces that Commure has joined the Affineon Embed™ Program. Through this partnership, Commure's industry-leading Ambient AI suite will embed Affineon's AI inbox product to deliver a unified solution for hospitals and health systems.Beyond the challenges of clinical documentation, the provider inbox also drives administrative overload and burnout. In fact, 57% of physicians identify automating documentation and inbox management as the most impactful AI use case—an issue that aligns with the growing clinician burnout crisis. Addressing the inbox challenge is the next key step in reducing administrative burdens. By integrating Affineon's AI inbox with Commure's Ambient AI, providers gain a seamless solution that frees clinicians from routine tasks while keeping them "in workflow." This pairing enables a streamlined EHR integration, simplified implementation, and unified preference management for end users and health systems.The Affineon Embed™ Program allows AI scribes, EHR vendors, and other healthcare technology providers to integrate Affineon's AI inbox management system into their platforms. By embedding Affineon's technology, Commure enhances its AI Scribe offering with automated inbox triage, lab result management, and prescription renewal workflows—empowering providers to reduce administrative burdens and focus more on patient care.Expanding Industry PartnershipsThe addition of Commure to Affineon's Embed Program is one of many strategic collaborations underway

What You Should Know:– Commure, a healthcare technology company, today announced that North East Medical Services (NEMS) has selected Commure Ambient AI for enterprise-wide deployment across its network of clinics.– The implementation follows a successful ten-week pilot program comparing Commure’s AI-powered scribe solution with another leading vendor.NEMS BackgroundNEMS, a non-profit community health center serving diverse populations in San Francisco and Daly City, prioritized finding an AI solution that could accurately capture and transcribe clinical conversations in multiple languages, streamline workflows, and integrate seamlessly with their Epic electronic health record (EHR) system.Commure Ambient AI Excels in Pilot ProgramDuring the pilot program, Commure Ambient AI demonstrated superior performance in several key areas:Multilingual Accuracy: Commure achieved significantly higher accuracy rates for Spanish and Chinese-language encounters compared to the competitor, with documentation edit rates of 95% and 93%, respectively.Commure achieved significantly higher accuracy rates for Spanish and Chinese-language encounters compared to the competitor, with documentation edit rates of 95% and 93%, respectively. Documentation Efficiency: Commure delivered a 30% improvement in documentation efficiency, saving clinicians an average of 5.2 minutes per encounter.Commure delivered a 30% improvement in documentation efficiency, saving clinicians an average of 5.2 minutes per encounter. Provider Satisfaction: Physicians rated Commure Ambient AI an average of 4.5 out of 5 for note quality, compared to 3.8 for the competitor.Physicians rated Commure Ambient AI an average of 4.5 out of 5 for note quality, compared to 3.8 for the competitor. Seamless Epic Integration: Commure’s solution integrated smoothly with NEMS’s Epic workflows, particularly with workstations.Commure Ambient AI’s flexible workflows, including in-Epic recording, desktop app, and mobile compatibility, allowed NEMS providers to efficiently document visits across various settings. The platform’s potential for future AI applications, such as provider copilots and computer vision modules, also played a significant role in NEMS’s decision

Digital healthcare is at a pivotal moment, with innovation, funding and expansion creating new opportunities and challenges for startups and established companies. In 2024, digital health venture funding reached $10.1 billion, slightly down from the previous year but still surpassing pre-pandemic levels. Most of these funds have been directed toward early-stage ventures, especially in areas like nonclinical workflows, mental health and obesity care. Late-Stage Funding Declines Drive MA Activity. However, a decline in later-stage funding reveals larger companies are facing more difficulty securing capital, potentially leading to consolidation and partnerships